James Warren Huff, Chief Executive Officer at REATA PHARMACEUTICALS INC (RETA), sold 146,525 shares at $87.61 ($12.5M) on 2023-03-02, disclosed to the SEC on 2023-03-03.
Open-market sale of $12.5M RETA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.49 | 8,104 | $660K | 5.3% |
| 2 | $81.49 | 8,104 | $660K | 5.3% |
| 3 | $82.20 | 12,132 | $997K | 8.0% |
| 4 | $82.20 | 12,132 | $997K | 8.0% |
| 5 | $83.31 | 9,660 | $805K | 6.4% |
| 6 | $83.31 | 9,660 |
| $805K |
| 6.4% |
| 7 | $84.33 | 7,439 | $627K | 5.0% |
| 8 | $84.33 | 7,439 | $627K | 5.0% |
| 9 | $85.25 | 6,395 | $545K | 4.4% |
| 10 | $85.25 | 6,395 | $545K | 4.4% |
| 11 | $86.44 | 3,475 | $300K | 2.4% |
| 12 | $87.61 | 4,034 | $353K | 2.8% |
| 13 | $87.61 | 4,034 | $353K | 2.8% |
| 14 | $88.59 | 12,826 | $1.1M | 9.1% |
| 15 | $88.59 | 12,826 | $1.1M | 9.1% |
| 16 | $89.49 | 5,742 | $514K | 4.1% |
| 17 | $89.49 | 5,742 | $514K | 4.1% |
| 18 | $90.57 | 4,623 | $419K | 3.3% |
| 19 | $90.57 | 4,623 | $419K | 3.3% |
| 20 | $91.12 | 570 | $52K | 0.4% |
| 21 | $91.12 | 570 | $52K | 0.4% |
| Total | $85.44 avg | 146,525 | $12.5M | 100% |
| Filing → |
| RETA | BUY | 2016-06-02 | $1.3M | — | Filing → |